Covaxin statement amid AstraZeneca row

Amid AstraZeneca row, Bharat Biotech boasts of Covaxin’s excellent safety record. See full statement

Amid AstraZeneca row, Bharat Biotech boasts of Covaxin’s excellent safety record. See full statement

Lawrence Booth

Amid a debate over AstraZeneca’s admission that its Covid-19 vaccine, sold as Covishield in India, could cause “rare” side effects, ...